Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC50112 NCL 00017509 A Nek2 inhibitor
  3. GC50109 AZD 5582 dihydrochloride A Smac mimetic and IAP inhibitor
  4. GC50063 rac-CCT 250863 rac-CCT 250863 (compound rac-21) 是一种选择性和可逆的 NEK 2 抑制剂,IC50 为 0.073 µM。 rac-CCT 250863 表现出良好的诱导细胞周期停滞的作用,并且还可以在细胞中进行抗增殖(Pomalidomide 敏感/抗性)。 rac-CCT 250863 与 Pomalidomide 结合时可诱导细胞凋亡。
  5. GC50045 PD 166285 dihydrochloride

    6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮盐酸盐

    A tyrosine kinase inhibitor
  6. GC50009 LY 294002 hydrochloride Prototypical PI 3-kinase inhibitor; also inhibits other kinases
  7. GC39302 PARP14 inhibitor H10 PARP14 inhibitor H10 (化合物 H10) 是针对 PARP14 的选择性抑制剂 (IC50=490 nM),是其他 PARP 的抑制剂 (约为 PARP1 的 24 倍)。PARP14 抑制剂 H10 诱导 caspase-3/7 介导的细胞凋亡 (apoptosis)。
  8. GC39296 1G244 1G244 是一种有效的 DPP8/9 抑制剂,IC50 分别为 12 nM 和 84 nM,但不抑制 DPPIV 和 DPPII。1G244 可诱导多发性骨髓瘤细胞凋亡,并具有抗骨髓瘤作用。
  9. GC39295 DJ001 DJ001 是一种高度特异性,选择性和非竞争性的蛋白酪氨酸磷酸酶-σ (PTPσ) 抑制剂,IC50 为 1.43 μM。DJ001 对其他磷酸酶无抑制活性,对蛋白质磷酸酶 5 仅有中等抑制活性。DJ001 促进造血干细胞再生。
  10. GC39281 (R)-CR8 trihydrochloride

    CR8, (R)-Isomer trihydrochloride

    An inhibitor of cyclin-dependent kinases
  11. GC39266 Hematein

    氧化苏木精

    Hematein inhibits casein kinase II activity in a selective, dose-dependent and ATP non-competitive manner in vitro, with IC50 of 0.55 μM in the presence of 10 μM ATP.
  12. GC39232 Valepotriate

    戊曲酯,Valtrate

    A valepotriate with diverse biological activities
  13. GC39209 LCH-7749944

    GNF-PF-2356

    LCH-7749944 (GNF-PF-2356) is a novel and potent p21-activated kinase 4 (PAK4) inhibitor with an IC50 of 14.93 μM and has less potently inhibitory effect against PAK1, PAK5 and PAK6. LCH-7749944 causes successful inhibition of EGFR activity due to its inhibitory effect on PAK4.
  14. GC46238 Yatein

    亚太因

    A lignan with diverse biological activities
  15. GC46222 SLM6031434 (hydrochloride) An SPHK2 inhibitor
  16. GC46218 Satratoxin G A macrocyclic trichothecene mycotoxin
  17. GC46159 Histone H2AX (134-143) (human) (trifluoroacetate salt)

    H-Lys-Lys-Ala-Thr-Gln-Ala-Ser-Gln-Glu-Tyr-OH, KKATQASQEY

    A neuropeptide with diverse biological activities
  18. GC46113 CAY10744 A topoisomerase II-α poison
  19. GC46104 Butyric Acid-d7

    氘代丁酸(D7),Butanoic acid-d7

    An internal standard for the quantification of sodium butyrate
  20. GC46057 2,5-Dihydroxycinnamic Acid phenethyl ester An inhibitor of 5-LO
  21. GC39182 Soyasaponin III

    大豆皂苷 III

    Soyasaponin III 是一类单链齐墩果烷三萜类化合物,是大豆 (Glycine max) 及其相关产品中发现的主要潜在生物活性皂苷之一。Soyasaponin III 可以诱导 Hep-G2 细胞凋亡。
  22. GC39175 SR-4835 SR-4835 is a highly selective dual inhibitor of CDK12 and CDK13 with IC50 of 99 nM and Kd of 98 nM for CDK12 and IC50 of 4.9 nM for CDK13. SR-4835 disables triple-negative breast cancer (TNBC) cells. SR-4835 promotes synergy with DNA-damaging chemotherapy and PARP inhibitors.
  23. GC39174 EC359 EC359 是一种有效的,选择性的,高亲和力的和口服的生物利用度白血病抑制因子受体 (LIFR) 抑制剂,其 Kd 值为 10.2 nM,可直接与 LIFR 相互作用以有效阻断 LIF/LIFR 相互作用。
  24. GC39169 CC-92480

    CC-92480

    A modulator of cereblon
  25. GC39167 VBIT-4 VBIT-4 is a voltage-dependent anion channel (VDAC) oligomerization inhibitor that decreases mitochondrial DNA (mtDNA) release, type I interferon (IFN) signaling, neutrophil extracellular traps, and disease severity in a mouse model of systemic lupus erythematosus.
  26. GC39155 PI-273 PI-273, the first reversibly and specific phosphatidylinositol 4-kinase (PI4KIIα) inhibitor with an IC50 of 0.47 μM, can inhibit breast cancer cell proliferation, block the cell cycle and induce cell apoptosis.
  27. GC39152 9-ING-41

    Elraglusib

    A GSK3β inhibitor
  28. GC39135 Ranaconitine

    7-羟基高乌甲素

    An alkaloid with analgesic and anesthetic activities
  29. GC39094 Thonningianin A Thonningianin A 是一种鞣花素,从非洲草药通宁宁的甲醇提取物中分离得到。Thonningianin A 的抗氧化特性包括自由基清除、抗超氧物生成和金属螯合作用。具有抗癌活性。
  30. GC39070 Negletein

    黄芩素-7-甲醚; 5,6-Dihydroxy-7-methoxyflavone

    Negletein 是一种神经保护剂,可增强神经生长因子的作用并诱导 PC12 细胞中的神经突向外生长。Negletein 通过抑制 TNF-α 和 IL-1β 表现出有希望的抗炎活性,其 IC50 值分别为 16.4 和 10.8 μM。
  31. GC39069 Poncirin

    枸橘甙

    A flavonoid glycoside with diverse biological activities
  32. GC39063 Prosapogenin A

    重楼皂苷E,Progenin III

    Prosapogenin A 是藜芦中的天然产物,通过抑制 STAT3 信号通路和糖酵解,在体外诱导人癌细胞凋亡。
  33. GC39062 Kumatakenin

    熊竹素

    A flavonoid with diverse biological activities
  34. GC39041 Polyporenic acid C

    聚孔酸C

    Polyporenic acid C 是从 P. cocos 中分离出的羊毛甾烷型三萜。Polyporenic acid C 通过死亡受体介导的凋亡途径诱导细胞凋亡 (apoptosis),而无需线粒体的参与。 Polyporenic acid C 是治疗肺癌的有前途的药物。
  35. GC39040 Taraxerol acetate

    醋酸蒲公英霜

    Taraxerol acetate 是 COX-1 和 COX-2 抑制剂, IC50 值分别为 116.3 μM 和 94.7μM。Taraxerol acetate 具有抗癌作用并诱导细胞凋亡(apoptosis)。
  36. GC39022 Tetramethylcurcumin

    四甲基姜黄素; FLLL31

    Tetramethylcurcumin (FLLL31), a small-molecule signal transducer and activator of transcription 3 (STAT3) inhibitor derived from curcumin, binds selectively to Janus kinase 2 and the STAT3 Src homology-2 domain, which serve crucial roles in STAT3 dimerization and signal transduction.
  37. GC38973 Osmundacetone

    紫萁酮

    Osmundacetone 是从 Osmundae Rhizoma 中分离出的一种天然产物。
  38. GC38970 Sophoraflavanone G

    槐黄烷酮G,Kushenol F

    A flavonoid with diverse biological activities
  39. GC38969 Neogambogic acid

    新藤黄酸

    Neogambogic acid 是藤黄的有效成分,可诱导细胞凋亡并具有抗癌作用。 Neogambogic acid 对耐甲氧西林的金黄色葡萄球菌 (MRSA) 具有明显的抑制活性。
  40. GC38967 Lycorine

    石蒜碱

    An alkaloid with diverse biological activities
  41. GC38943 PROTAC Mcl1 degrader-1 PROTAC Mcl1 degrader-1 (compound C3) 是一种靶向嵌合体的蛋白水解 (PROTAC),是有效,选择性的 Mcl-1 抑制剂,IC50 为 0.7 μM。PROTAC Mcl1 degrader-1 通过将具有微摩尔范围亲和力的 E3 连接酶脑 (CRBN) 结合配体 pomalidomide 引入 Mcl-1 抑制剂 S1-6 来诱导 Mcl-1 的泛素化和蛋白酶体降解。
  42. GC38941 PROTAC Bcl2 degrader-1 PROTAC Bcl2 degrader-1 (Compound C5) 是一种 PROTAC,通过将 E3 连接酶 cereblon 的配体 pomalidomide 引入到 Mcl-1/Bcl-2 的双重抑制剂 Nap-1,来有效、特异性地诱导 Bcl-2 (IC50,4.94 μM;DC50,3.0 μM) 和 Mcl-1 (IC50,11.81 μM) 的降解。
  43. GC38928 MCL-1/BCL-2-IN-3 MCL-1/BCL-2-IN-3 (Compound 2) 是一种有效的选择性 Mcl-1 和 Bcl-2 抑制剂,IC50 分别为 5.95 和 4.78 μM。
  44. GC38927 MCL-1/BCL-2-IN-2 MCL-1/BCL-2-IN-2 (Compound 6) 是一种有效的选择性 Mcl-1 和 Bcl-2 抑制剂。
  45. GC46031 Malabaricone B

    NSC 287967, NSC 630196

    A diarylnonanoid with diverse biological activities
  46. GC46028 Malabaricone C

    马拉巴酮C

    A diarylnonanoid with diverse biological activities
  47. GC46027 IP7e

    Isoxazolo-pyridinone 7e

    An activator of Nurr1 signaling
  48. GC46020 Stachybotrysin B A fungal metabolite with antiviral and anticancer activities
  49. GC46015 KY 05009 A TNIK inhibitor
  50. GC46008 (±)-Thalidomide-d4

    沙利度胺 D4

    An internal standard for the quantification of (±)-thalidomide
  51. GC46006 Terpendole I A fungal metabolite

Items 1101 to 1150 of 2733 total

per page

Set Descending Direction